Cancer stem cells in urooncology

Yüce Z., Cal C.

Critical Reviews in Oncogenesis, vol.24, no.1, pp.89-98, 2019 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.1615/critrevoncog.2019029657
  • Journal Name: Critical Reviews in Oncogenesis
  • Journal Indexes: Scopus
  • Page Numbers: pp.89-98
  • Keywords: Bladder cancer, Cancer stem cells, Kidney cancer, Prostate cancer
  • Dokuz Eylül University Affiliated: Yes


© 2019 Begell House, Inc.The aging of society has led to an increase in the incidence of urological cancers. Surgery, radiotherapy, and chemotherapeutic agents are widely used treatment options, in addition to minimally invasive new therapeutical approaches developed in the past decade. Unfortunately, we are still a long way from preventing mortality due to urological cancers or to achieving long-term progression-free disease control. Extensive research in recent years has established the presence of a relatively small population of cancer stem cells, which may be targeted to reach these goals. Mounting evidence points to the role of CSCs in metastasis, treatment resistance, and recurrence. In this chapter, we review the presence of CSCs in bladder, prostate, and kidney cancers with emphasis on their identification and clinical relevance.